"The Medidata products are very innovative and support our very complex oncology studies."
”Having the RTSM, Coder, and Rave EDC, all [on] one platform makes the integration much more seamless…My reason why I would suggest using Medidata is that the service has been great. The response time has been fantastic, and I always know exactly who to go to if an issue arises or [when] I need the build to be done ‘quick lightning,’ The response time from Medidata has been super.”
“Medidata’s choice to implement the Rave eCOA/ ePRO solution in a unified environment with Rave EDC allows the user to extend their study design knowledge and ease the ePRO design, especially for beginners.“
“We have a strong partnership that goes way beyond a service provider relationship and enables us to drive high-quality analysis that would otherwise not be possible.”
“We chose to partner with Medidata because we recognize that we need an innovative technology partner with deep understanding of CROs and sites and sponsors in order for us to excel in this market. Medidata delivers the right platform, expertise and services that will allow us to be competitive and aggressively scale our full service offerings.”
"Using MS Word documents for visit reporting wasted our CRAs’ time and the reviewer’s time. With Medidata’s cloud-based CTMS, which structures visit report data, CRAs spend 40 percent less time completing a report and site correspondences. We’ve also noticed a reduction in review-to-approval cycle times from 16 days to seven days."
“By using a system - that both the pharmaceutical industry recognizes, and the regulators accept - to execute high quality clinical trials, our mission to bring better treatments to patients faster can, ultimately, be realized.”
"We want to use the best in-class technology and we want to combine that with our clinical research."
“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”
"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”
“One of the things that attracted me to Medidata was their ability to have a support mechanism [beyond] internal experts. Having a broad reach across the globe and supporting end users with devices are important. These factors attracted me to the Medidata DCT Program because not all competitors have that reach with their help desk and device support. It’s nice to have a reputable organization that allows us to lean on."
“We don’t compromise on quality, and we are always innovating and striving for improvement. In Medidata, we have found a technology partner that does the same. Medidata is renowned as one of the best companies in terms of technological solutions for clinical trials.”
“We used to do all the reconciliation manually. With the Rave Site Payment, it’s automated the payments not only from a sponsor’s perspective but also from the site’s perspective. Sites don’t have to do anything additional. From a sponsor perspective, we have all the line item details. We can see what’s paid to the site [and] what’s outstanding. The same applies to the sites. They can go into the system, see what’s been paid and what’s outstanding, and then work collaboratively to fix or expedite things if needed.”
"We needed to find a trusted partner to work with us, to grow with us AND deliver and provide innovative technology solutions for our clinical trials, we found that partner in Medidata."
"We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."